490 related articles for article (PubMed ID: 27309056)
1. Protection Afforded by a Recombinant Turkey Herpesvirus-H5 Vaccine Against the 2014 European Highly Pathogenic H5N8 Avian Influenza Strain.
Steensels M; Rauw F; van den Berg T; Marché S; Gardin Y; Palya V; Lambrecht B
Avian Dis; 2016 May; 60(1 Suppl):202-9. PubMed ID: 27309056
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).
Pantin-Jackwood MJ; Kapczynski DR; DeJesus E; Costa-Hurtado M; Dauphin G; Tripodi A; Dunn JR; Swayne DE
Avian Dis; 2016 Mar; 60(1):22-32. PubMed ID: 26953940
[TBL] [Abstract][Full Text] [Related]
3. Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
Kilany WH; Safwat M; Mohammed SM; Salim A; Fasina FO; Fasanmi OG; Shalaby AG; Dauphin G; Hassan MK; Lubroth J; Jobre YM
PLoS One; 2016; 11(6):e0156747. PubMed ID: 27304069
[TBL] [Abstract][Full Text] [Related]
4. Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses.
Kapczynski DR; Pantin-Jackwood MJ; Spackman E; Chrzastek K; Suarez DL; Swayne DE
Vaccine; 2017 Nov; 35(46):6345-6353. PubMed ID: 28456525
[TBL] [Abstract][Full Text] [Related]
5. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
[TBL] [Abstract][Full Text] [Related]
6. Vaccine Protection of Turkeys Against H5N1 Highly Pathogenic Avian Influenza Virus with a Recombinant Turkey Herpesvirus Expressing the Hemagglutinin Gene of Avian Influenza.
Kapczynski DR; Dorsey K; Chrzastek K; Moraes M; Jackwood M; Hilt D; Gardin Y
Avian Dis; 2016 Jun; 60(2):413-7. PubMed ID: 27309280
[TBL] [Abstract][Full Text] [Related]
7. Examination of the protective efficacy of two avian influenza H5 vaccines against clade 2.3.4.4b H5N8 highly pathogenic avian influenza virus in commercial broilers.
El-Shall NA; Awad AM; Sedeik ME
Res Vet Sci; 2021 Nov; 140():125-133. PubMed ID: 34425414
[TBL] [Abstract][Full Text] [Related]
8. Experimental and Field Results Regarding Immunity Induced by a Recombinant Turkey Herpesvirus H5 Vector Vaccine Against H5N1 and Other H5 Highly Pathogenic Avian Influenza Virus Challenges.
Gardin Y; Palya V; Dorsey KM; El-Attrache J; Bonfante F; Wit Sd; Kapczynski D; Kilany WH; Rauw F; Steensels M; Soejoedono RD
Avian Dis; 2016 May; 60(1 Suppl):232-7. PubMed ID: 27309060
[TBL] [Abstract][Full Text] [Related]
9. Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens.
Zeng X; Chen P; Liu L; Deng G; Li Y; Shi J; Kong H; Feng H; Bai J; Li X; Shi W; Tian G; Chen H
Avian Dis; 2016 May; 60(1 Suppl):253-5. PubMed ID: 27309064
[TBL] [Abstract][Full Text] [Related]
10. Protection conferred by recombinant turkey herpesvirus avian influenza (rHVT-H5) vaccine in the rearing period in two commercial layer chicken breeds in Egypt.
Kilany W; Dauphin G; Selim A; Tripodi A; Samy M; Sobhy H; VonDobschuetz S; Safwat M; Saad M; Erfan A; Hassan M; Lubroth J; Jobre Y
Avian Pathol; 2014; 43(6):514-23. PubMed ID: 25245772
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a Recombinant Turkey Herpesvirus AI (H5) Vaccine in Preventing Transmission of Heterologous Highly Pathogenic H5N8 Clade 2.3.4.4b Challenge Virus in Commercial Broilers and Layer Pullets.
Palya V; Tatár-Kis T; Walkóné Kovács E; Kiss I; Homonnay Z; Gardin Y; Kertész K; Dán Á
J Immunol Res; 2018; 2018():3143189. PubMed ID: 30584541
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a recombinant HVT-H5 vaccine against challenge with two genetically divergent Indonesian HPAI H5N1 strains.
Soejoedono RD; Murtini S; Palya V; Felföldi B; Mató T; Gardin Y
Avian Dis; 2012 Dec; 56(4 Suppl):923-7. PubMed ID: 23402113
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Turkey Herpesvirus-AI Vaccine Virus Replication in Different Species of Waterfowl.
Palya V; Kovács EW; Tatár-Kis T; Felföldi B; Homonnay ZG; Mató T; Sato T; Gardin Y
Avian Dis; 2016 May; 60(1 Suppl):210-7. PubMed ID: 27309057
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effectiveness of rHVT-H5, inactivated H5 and rHVT-H5 with inactivated H5 prime/boost vaccination regimes in commercial broiler chickens carrying MDAs against HPAI H5N1 clade 2.2.1 virus.
Kilany WH; Hassan MK; Safwat M; Mohammed S; Selim A; VonDobschuetz S; Dauphin G; Lubroth J; Jobre Y
Avian Pathol; 2015 Oct; 44(5):333-41. PubMed ID: 26023824
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge.
Bublot M; Pritchard N; Cruz JS; Mickle TR; Selleck P; Swayne DE
Avian Dis; 2007 Mar; 51(1 Suppl):498-500. PubMed ID: 17494618
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of clade 2.3.2 H5 commercial vaccines in protecting chickens from clade 2.3.4.4 H5N8 highly pathogenic avian influenza infection.
Yuk SS; Erdene-Ochir TO; Kwon JH; Noh JY; Hong WT; Jeong JH; Jeong S; Gwon GB; Shin JI; Sur JH; Song CS
Vaccine; 2017 Mar; 35(9):1316-1322. PubMed ID: 28169074
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of rHVT-AI vector vaccine in broilers with passive immunity against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains.
Rauw F; Palya V; Gardin Y; Tatar-Kis T; Dorsey KM; Lambrecht B; van den Berg T
Avian Dis; 2012 Dec; 56(4 Suppl):913-22. PubMed ID: 23402112
[TBL] [Abstract][Full Text] [Related]
18. Herpesvirus of turkey-vectored avian influenza vaccine offers cross-protection against antigenically drifted H5Nx highly pathogenic avian influenza virus strains.
Nassif S; Zaki F; Mourad A; Fouad E; Saad A; Setta A; Felföldi B; Mató T; Kiss I; Palya V
Avian Pathol; 2020 Dec; 49(6):547-556. PubMed ID: 32615785
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of recombinant turkey herpesvirus vaccines targeting the H5 of highly pathogenic avian influenza virus from the 2014-2015 North American outbreak.
Balzli CL; Bertran K; Lee DH; Killmaster L; Pritchard N; Linz P; Mebatsion T; Swayne DE
Vaccine; 2018 Jan; 36(1):84-90. PubMed ID: 29180030
[TBL] [Abstract][Full Text] [Related]
20. Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains.
Rauw F; Palya V; Van Borm S; Welby S; Tatar-Kis T; Gardin Y; Dorsey KM; Aly MM; Hassan MK; Soliman MA; Lambrecht B; van den Berg T
Vaccine; 2011 Mar; 29(14):2590-600. PubMed ID: 21292007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
